inactivated poliovirus type 2 mef-1

Ukraine

Drugs containing this active substance

IMOVAX POLIO® VACCINE FOR PROPHYLAXIS OF POLIOMYELITIS INACTIVATED LIQUID

The vaccine is used for the prevention of poliomyelitis in infants, children, and adults through primary vaccination or revaccination (administration of booster doses).

Form: suspension for injection

Active substance	Dosage
inactivated poliovirus type 1 mahoney	40 units D antigen
inactivated poliovirus type 2 mef-1	8 units of D antigen
inactivated poliovirus type 3 saukett	32 units D antigen

Manufacturer: Sanofi Pasteur (manufacturing of unpackaged product, quality control of unpackaged product, secondary packaging, quality control and batch release (for pre-filled syringes); manufacturing of unpackaged product, quality control of unpackaged product, filling (primary packaging), secondary packaging, quality control and batch release (for vials); manufacturing of unpackaged product, quality control of unpackaged product, filling (primary packaging) and inspection, secondary packaging, quality control and batch release (for pre-filled syringes); manufacturing of unpackaged product, quality control of unpackaged product, filling (primary packaging), secondary packaging, quality control and batch release (for vials))